Durham, N.C.-based Med-El North America received a thumbs up from the FDA for use of its cochlear implant systems in people with single-sided deafness (SSD) and asymmetrical hearing loss (AHL). The July 19 approval marks the first time that Americans with these two indications are eligible for the surgically implanted electronic device, which until now has been limited to people with profound or severe bilateral hearing loss.